Medicine & Life Sciences
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
78%
5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide
18%
Antipsychotic Agents
46%
Behavioral Symptoms
61%
Body Weight Changes
15%
Caregivers
6%
Chronic Disease
7%
Communication
5%
Communication Barriers
9%
Community Health Services
9%
Databases
18%
Delivery of Health Care
18%
Dementia
42%
England
7%
Fasting
10%
Focus Groups
13%
General Practice
49%
General Practitioners
13%
Glucose
7%
Gray Literature
12%
Health Services
8%
Hemoglobins
30%
Hyperglycemia
11%
Hypoglycemic Agents
12%
Medical Subject Headings
14%
MEDLINE
8%
Pharmaceutical Preparations
20%
Pharmacies
8%
Pharmacists
100%
Placebos
17%
Politics
8%
Prescriptions
6%
Primary Health Care
39%
Psychology
34%
Quality of Life
6%
Randomized Controlled Trials
34%
Sodium-Glucose Transporter 2 Inhibitors
18%
Symporters
17%
Systematic Reviews
37%
Therapeutics
5%
Type 2 Diabetes Mellitus
9%